Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease

Metabolic syndrome (MS) and Non-Alcoholic Fatty Liver Disease (NAFLD) spectrum disorder share commonrisk factors namely obesity, hypertension, diabetes mellitus, and dyslipidemia, and hence, there is evidencenow to show that NAFLD may actually be a hepatic manifestation of MS. Moreover, the presence of NAFLDin a patient with metabolic syndrome increases the risk of cardiovascular events and other co-morbidities.Hence there is a need to develop an integrated preventive and therapeutic approach for both these conditionsand not treat them as separate entities.